AB
CTXR icon

Amalgamated Bank’s Citius Pharmaceuticals CTXR Stock Holding History

Amalgamated Bank’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-166
Closed -$4K – 3034
2024
Q1 		$4K Sell
166
-292
-64% -$5.33K ﹤0.01% 2766
2023
Q4 		$9K Sell
458
-49
-10% -$929 ﹤0.01% 2873
2023
Q3 		$9K Hold
507
– – ﹤0.01% 2911
2023
Q2 		$15K Buy
+507
New +$16.7K ﹤0.01% 2863
2022
Q2 		– Sell
-549
Closed -$25K – 3068
2022
Q1 		$25K Sell
549
-42
-7% -$1.66K ﹤0.01% 2731
2021
Q4 		$23K Sell
591
-21
-3% -$953 ﹤0.01% 2140
2021
Q3 		$31K Sell
612
-27
-4% -$1.35K ﹤0.01% 2151
2021
Q2 		$56K Buy
+639
New +$38.4K ﹤0.01% 2157

Other funds holding CTXR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amalgamated Bank's CTXR Position: Q2 2024 in Review

Amalgamated Bank sold out of Citius Pharmaceuticals (CTXR) in Q2 2024, closing a stake of 166 shares — an estimated $4K sold.

Amalgamated Bank first reported a position in CTXR in Q2 2021 and held it in 8 quarters. The position peaked at $56K in Q2 2021. 72 funds tracked by Wall St. Rank hold CTXR as of Q2 2024.

  • Amalgamated Bank reported no remaining Citius Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 166 Citius Pharmaceuticals shares in Q2 2024, an estimated $4K.
  • Amalgamated Bank first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 8 quarters.
  • Amalgamated Bank's Citius Pharmaceuticals position peaked at $56K in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.